Jyoti Madhusoodanan is a freelance science writer based in Portland, Oregon.
Jyoti Madhusoodanan
From this contributor
Confusion at the crossroads of autism and hearing loss
Hearing difficulties and autism often overlap, exacerbating autism traits and complicating diagnoses.
Confusion at the crossroads of autism and hearing loss
Mutations in cancer gene tied to unique autism traits
Autistic people who carry mutations in a gene called PTEN have distinct behavioral and motor problems.
Mutations in cancer gene tied to unique autism traits
Analysis finds little evidence to support dietary interventions for autism
Special diets that eliminate certain foods or contain added supplements have minimal impact on autism traits, according to a review of 27 clinical trials.
Analysis finds little evidence to support dietary interventions for autism
Studies of autism treatments lack standard yardsticks
Clinical trials of autism treatments rarely use a consistent set of tools to measure efficacy, making it tough to compare the treatments.
Studies of autism treatments lack standard yardsticks
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.